Highlander Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $286K | Sell |
367
-100
| -21% | -$71.2K | 0.1% | 158 |
|
|
2023
Q4 | $272K | Hold |
467
| – | – | 0.1% | 162 |
|
|
2023
Q3 | $251K | Buy |
467
+100
| +27% | +$51.5K | 0.1% | 163 |
|
|
2023
Q2 | $172K | Hold |
367
| – | – | 0.08% | 172 |
|
|
2023
Q1 | $126K | Sell |
367
-200
| -35% | -$67.5K | 0.06% | 201 |
|
|
2022
Q4 | $207K | Hold |
567
| – | – | 0.11% | 146 |
|
|
2022
Q3 | $183K | Hold |
567
| – | – | 0.11% | 139 |
|
|
2022
Q2 | $184K | Hold |
567
| – | – | 0.1% | 150 |
|
|
2022
Q1 | $162K | Hold |
567
| – | – | 0.08% | 166 |
|
|
2021
Q4 | $157K | Buy |
567
+260
| +85% | +$65.9K | 0.07% | 167 |
|
|
2021
Q3 | $71K | Hold |
307
| – | – | 0.04% | 239 |
|
|
2021
Q2 | $70K | Hold |
307
| – | – | 0.04% | 253 |
|
|
2021
Q1 | $57K | Sell |
307
-50
| -14% | -$9.78K | 0.03% | 268 |
|
|
2020
Q4 | $60K | Hold |
357
| – | – | 0.03% | 257 |
|
|
2020
Q3 | $53K | Hold |
357
| – | – | 0.03% | 273 |
|
|
2020
Q2 | $59K | Hold |
357
| – | – | 0.04% | 256 |
|
|
2020
Q1 | $50K | Hold |
357
| – | – | 0.04% | 276 |
|
|
2019
Q4 | $47K | Hold |
357
| – | – | 0.03% | 313 |
|
|
2019
Q3 | $40K | Hold |
357
| – | – | 0.02% | 328 |
|
|
2019
Q2 | $40K | Sell |
357
-1,000
| -74% | -$118K | 0.02% | 348 |
|
|
2019
Q1 | $176K | Hold |
1,357
| – | – | 0.11% | 165 |
|
|
2018
Q4 | $156K | Buy |
1,357
+1,000
| +280% | +$112K | 0.1% | 181 |
|
|
2018
Q3 | $38K | Hold |
357
| – | – | 0.02% | 396 |
|
|
2018
Q2 | $30K | Hold |
357
| – | – | 0.02% | 426 |
|
|
2018
Q1 | $27K | Hold |
357
| – | – | 0.02% | 438 |
|
|
2017
Q4 | $30K | Hold |
357
| – | – | 0.02% | 427 |
|
|
2017
Q3 | $31K | Hold |
357
| – | – | 0.02% | 425 |
|
|
2017
Q2 | $30K | Sell |
357
-500
| -58% | -$40.8K | 0.02% | 435 |
|
|
2017
Q1 | $72K | Hold |
857
| – | – | 0.06% | 288 |
|
|
2016
Q4 | $63K | Buy |
857
+500
| +140% | +$37.2K | 0.05% | 296 |
|
|
2016
Q3 | $29K | Hold |
357
| – | – | 0.03% | 450 |
|
|
2016
Q2 | $28K | Hold |
357
| – | – | 0.03% | 465 |
|
|
2016
Q1 | $26K | Hold |
357
| – | – | 0.02% | 471 |
|
|
2015
Q4 | $30K | Hold |
357
| – | – | 0.03% | 448 |
|
|
2015
Q3 | $29K | Hold |
357
| – | – | 0.03% | 469 |
|
|
2015
Q2 | $30K | Hold |
357
| – | – | 0.03% | 461 |
|
|
2015
Q1 | $26K | Hold |
357
| – | – | 0.02% | 506 |
|
|
2014
Q4 | $25K | Hold |
357
| – | – | 0.02% | 513 |
|
|
2014
Q3 | $23.2K | Hold |
357
| – | – | 0.02% | 507 |
|
|
2014
Q2 | $22.2K | Hold |
357
| – | – | 0.02% | 508 |
|
|
2014
Q1 | $21K | Hold |
357
| – | – | 0.02% | 513 |
|
|
2013
Q4 | $18.2K | Hold |
357
| – | – | 0.02% | 543 |
|
|
2013
Q3 | $18K | Hold |
357
| – | – | 0.02% | 545 |
|
|
2013
Q2 | $17.6K | Buy |
+357
| New | +$19.4K | 0.02% | 537 |
|
Other funds holding LLY
Highlander Capital Management's LLY Position: Q1 2024 in Review
Highlander Capital Management reduced its Eli Lilly (LLY) stake by 21% in Q1 2024, selling an estimated $71.2K and leaving 367 shares worth $286K. The position accounts for 0.1% of the portfolio, ranked #158.
Highlander Capital Management first reported a position in LLY in Q2 2013 and has held it in 44 quarters since. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.
- Highlander Capital Management held 367 shares of Eli Lilly worth $286K as of Q1 2024.
- Highlander Capital Management sold 100 Eli Lilly shares in Q1 2024, an estimated $71.2K.
- Eli Lilly made up 0.1% of Highlander Capital Management's portfolio in Q1 2024, its #158 holding.
- Highlander Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 44 quarters since.
- 3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.
Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.